Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress

Türkeş C., Söyüt H., Beydemir Ş.

PHARMACOLOGICAL REPORTS, vol.66, no.1, pp.74-80, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 1
  • Publication Date: 2014
  • Doi Number: 10.1016/j.pharep.2013.08.007
  • Journal Name: PHARMACOLOGICAL REPORTS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.74-80
  • Keywords: Paraoxonase, Nifedipine, Nitrendipine, Isradipine, Amlodipine besylate, HUMAN-SERUM PARAOXONASE, LOW-DENSITY-LIPOPROTEIN, DEPENDENT DIABETES-MELLITUS, IN-VITRO, LIPID-PEROXIDATION, MALONDIALDEHYDE LEVELS, MYOCARDIAL-INFARCTION, MACULAR DEGENERATION, NITRIC-OXIDE, RAT-LIVER
  • Erzincan Binali Yildirim University Affiliated: No

Abstract

Background: In this study, we investigated the in vitro effects of calcium channel blockers (nifedipine, nitrendipine, isradipine, and amlodipine besylate) on the activity of paraoxonase-1 (PON1).